Singhe Hospitals PLC Faces Valuation Challenges Amid Strong Sales Growth and Cash Flow
Singhe Hospitals PLC has recently adjusted its valuation, now classified as very expensive based on its financial metrics. The company reported a 13.97% increase in net sales, reaching LKR 466.58 million, and strong operating cash flow of LKR 262.07 million, despite facing challenges with its debt levels.
Singhe Hospitals PLC has recently undergone an adjustment in its evaluation, reflecting changes in its financial metrics and market position. The company's valuation grade has shifted to a classification indicating a very expensive status, with a P/E ratio reported at 18 and a Price to Book Value of 1.62. Additionally, the EV to EBIT and EV to EBITDA ratios stand at 6.16 and 4.68, respectively, suggesting a premium valuation compared to industry peers.Despite these valuation metrics, the company has demonstrated a notable growth in net sales, achieving a 13.97% increase, with the latest quarter reporting net sales of LKR 466.58 million. Operating cash flow has also reached a high of LKR 262.07 million, indicating strong cash generation capabilities. However, the company faces challenges with a Debt to EBITDA ratio of 1.39 times, which may impact its ability to service debt.
On the technical side, trends have shown a bullish sentiment in various indicators, including MACD and moving averages. Overall, Singhe Hospitals PLC continues to exhibit a complex financial landscape, characterized by strong sales growth and high valuation metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
